Fanconi Syndrome in Patients With Human Immunodeficiency Virus Treated With Tenofovir-Based Antiretroviral Therapy: A Systematic Literature Review

CONCLUSIONS: Occurrence of FS is low in patients with HIV treated with tenofovir-based regimens. Concomitant use of ritonavir may increase risk of FS. TAF may be a safer alternative than TDF in terms of nephrotoxicity.PMID:37932920 | DOI:10.1177/10600280231206703
Source: The Annals of Pharmacotherapy - Category: Drugs & Pharmacology Authors: Source Type: research